The Valley Desk

NCT03914794 · Interventional trial

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Overall registry status Active not recruiting

Phase 2

Conditions Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Cancer, Urothelial Carcinoma Recurrent

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov